Kleinman I, Schachter D, Koritar E
Department of Psychiatry, Mount Sinai Hospital, Toronto, Ont., Canada.
Am J Psychiatry. 1989 Jul;146(7):902-4. doi: 10.1176/ajp.146.7.902.
To determine whether a formalized informing process transmitted knowledge concerning the risks and benefits of neuroleptic medication, particularly the risk of tardive dyskinesia, to stable schizophrenic outpatients, the authors administered a multiple-choice questionnaire to 21 patients who were read a standardized information form and 27 patients who were not. The mean scores for the informed patients were significantly higher, and the differences between the two groups remained significant at 6-month follow-up. The information process had no adverse effects on frequency of psychiatric admission, noncompliance with medication, or the need for increased antipsychotic medication.
为了确定一种规范化的告知流程是否将有关抗精神病药物风险和益处的知识，尤其是迟发性运动障碍的风险，传达给了病情稳定的精神分裂症门诊患者，作者对21名听取了标准化信息表的患者和27名未听取的患者进行了多项选择题问卷调查。已被告知的患者的平均得分显著更高，且两组之间的差异在6个月的随访中仍然显著。该信息流程对精神科住院频率、药物治疗依从性或增加抗精神病药物的需求没有不良影响。
